Alexander A. Seelenberger - Mar 7, 2024 Form 4 Insider Report for Vincerx Pharma, Inc. (VINC)

Role
Chief Financial Officer
Signature
By: /s/ Alexander A. Seelenberger
Stock symbol
VINC
Transactions as of
Mar 7, 2024
Transactions value $
$0
Form type
4
Date filed
3/8/2024, 08:04 PM
Previous filing
Aug 14, 2023
Next filing
May 29, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VINC Stock Option (right to buy) Award $0 +93.8K $0.00 93.8K Mar 7, 2024 Common Stock 93.8K $7.38 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third (1/3) vests on March 7, 2025, with the remainder vesting in twenty-four equal monthly installments thereafter.